Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
X Financial A ADR | XYF | 28. mar 2025 | 15.90 | -1.24 |
X3 Holdings | XTKG | 28. mar 2025 | 1.22 | -1.61 |
X4 Pharmaceuticals | XFOR | 28. mar 2025 | 0.25 | -7.78 |
XAI Octagon Floating Rate & Alternative Income Term Trust | XFLT | 28. mar 2025 | 5.96 | +0.17 |
XAI Octagon Floating Rate & Alternative Income Term Trust 20 | XFLT-A | 28. mar 2025 | 25.19 | +0.04 |
XBiotech | XBIT | 28. mar 2025 | 3.10 | -4.32 |
XBP Europe | XBP | 28. mar 2025 | 1.26 | -8.70 |
Xcel Brands | XELB | 28. mar 2025 | 3.03 | -17.44 |
Xcel Energy | XEL | 28. mar 2025 | 69.72 | +0.58 |
XChange Tec.Inc ADR | XHG | 28. mar 2025 | 0.80 | -2.34 |
XCHG Limited - ADS | XCH | 28. mar 2025 | 1.26 | -3.08 |
Xencor | XNCR | 28. mar 2025 | 11.23 | -2.43 |
Xenetic Biosciences | XBIO | 28. mar 2025 | 3.12 | -4.30 |
Xenia Hotels & Resorts | XHR | 28. mar 2025 | 11.81 | -2.48 |
Xenon Pharmaceuticals | XENE | 28. mar 2025 | 34.26 | -0.58 |
Xeris Biopharma | XERS | 28. mar 2025 | 5.58 | -0.89 |
Xerox | XRX | 28. mar 2025 | 5.13 | -5.52 |
XIAO-I ADR | AIXI | 28. mar 2025 | 3.90 | -5.80 |
Xilio Therapeutics | XLO | 28. mar 2025 | 0.75 | +2.21 |
Xinyuan Real Estate ADR | XIN | 28. mar 2025 | 2.61 | -2.25 |
XOMA | XOMA | 28. mar 2025 | 20.33 | -3.05 |
XOMA A Pref | XOMAP | 28. mar 2025 | 25.78 | -0.58 |
XOMA B Pref | XOMAO | 28. mar 2025 | 25.43 | -0.09 |
Xometry A | XMTR | 28. mar 2025 | 25.89 | -2.67 |
XORTX Therapeutics | XRTX | 28. mar 2025 | 0.97 | +1.04 |
Xos | XOS | 28. mar 2025 | 3.44 | -3.37 |
XP A | XP | 28. mar 2025 | 14.80 | +0.89 |
XPEL | XPEL | 28. mar 2025 | 30.88 | -2.06 |
XPeng A ADR | XPEV | 28. mar 2025 | 19.70 | -2.48 |
Xperi | XPER | 28. mar 2025 | 7.84 | -4.51 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.